Our non-profit organization, Cure GABA-A Variants, has been focusing on groundbreaking research and the organization of a digital Natural History Study for the various GABA-A Variants. Founded in 2023, our mission was to address the urgent need for effective treatments for individuals affected by GABA-A Variants, a group of genetic disorders that cause debilitating neurological symptoms. Our organization has the sole focus of understanding the most efficient and effective way to develop potential therapies for GABA-A Variants. Together, we can create a future where effective treatments and therapies for GABA-A Variants are accessible to all, transforming lives and instilling hope in the lives of many children and adults alike.
Our vision is a future where individuals living with GABA-A Variants experience improved quality of life and have access to personalized treatments. We envision a world where repurposed FDA-approved drugs and gene therapies offer hope and relief to patients, effectively managing symptoms and addressing the underlying genetic causes of GABA-A Variants.